Complications neurologiques centrales des traitements anticancéreux, ce que le réanimateur doit savoir

作者: F. Bompaire , O. Aupee , D. Ricard , D. Psimaras

DOI: 10.1007/S13546-016-1252-X

关键词: EncephalopathyToxicityAnesthesiaProgressive multifocal leukoencephalopathyChemotherapyEpilepsyAnesthesiologyMedicineRadiation therapyIntensive care medicineDrug

摘要: Cerebral radiation therapy and chemotherapies can trigger central nervous system complications. For some products protocols, neurological toxicity is a dose-limiting parameter. Clinical characteristics including acute encephalopathy, epilepsy, posterior reversible progressive multifocal leukoencephalopathy, vascular events are well described. Numerous involved in these complications most have specific profile. As more complex regimens used, several cytotoxic drugs innovative targeted therapies, new profiles emerging. The determination of the drug precisely patients’ symptoms getting difficult. A good knowing implicated agents helps managing oncologic reanimation care. Oncological prognostic has to be considered therapeutic discussion.

参考文章(59)
S A W Fadilah, C F Leong, H S Teh, Transverse myelopathy following intrathecal administration of chemotherapy. Singapore Medical Journal. ,vol. 48, ,(2007)
Herbert B. Newton, Neurological complications of chemotherapy to the central nervous system. Handbook of Clinical Neurology. ,vol. 105, pp. 903- 916 ,(2012) , 10.1016/B978-0-444-53502-3.00031-8
S M Caryk, H G Chun, D F Hoth, B R Leyland-Jones, Central nervous system toxicity of fludarabine phosphate. Cancer treatment reports. ,vol. 70, pp. 1225- 1228 ,(1986)
Ofer Merimsky, Samario Chaitchik, Neurotoxicity of interferon-α Anti-Cancer Drugs. ,vol. 3, pp. 567- 570 ,(1992) , 10.1097/00001813-199212000-00002
Lauren Veltri, Quoc Van Truong, Mike Newton, Jame Abraham, Govardhanan Nagaiah, Gemcitabine Associated With Posterior Reversible Encephalopathy Syndrome (PRES): A Case Report and Review of the Literature Clinical advances in hematology & oncology. ,vol. 10, pp. 611- 613 ,(2012)
Shutaro Takashima, Yoshiharu Taguchi, Kortaro Tanaka, A case of phenytoin intoxication caused by interaction between phenytoin and capecitabine Brain and nerve. ,vol. 67, pp. 213- 217 ,(2015) , 10.11477/MF.1416200115
Yin Lo, Li-Jiuan Shen, Wen-Hwei Chen, Yaa-Hui Dong, Fe-Lin Lin Wu, Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis Journal of the Formosan Medical Association. ,vol. 115, pp. 744- 751 ,(2016) , 10.1016/J.JFMA.2015.07.016
Stefanie C Thust, Esther Blanco, Antony J Michalski, WK Chong, Mark N Gaze, Kim Phipps, Kshitij Mankad, MRI abnormalities in children following sequential chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa for high-risk primitive neuroectodermal tumours of the central nervous system. Journal of Medical Imaging and Radiation Oncology. ,vol. 58, pp. 683- 690 ,(2014) , 10.1111/1754-9485.12232
Dimitri Psimaras, Flavie Bompaire, Hervé Taillia, Damien Ricard, Sophie Taillibert, Complications neurologiques centrales des chimiothérapies cytotoxiques et des thérapies ciblées Bulletin Du Cancer. ,vol. 99, pp. 851- 863 ,(2012) , 10.1684/BDC.2012.1624
Kenneth R Carson, Scott D Newsome, Ellen J Kim, Nina D Wagner‐Johnston, Gloria Von Geldern, Craig H Moskowitz, Alison J Moskowitz, Alain H Rook, Pankaj Jalan, Alison W Loren, Daniel Landsburg, Thomas Coyne, Donald Tsai, Dennis W Raisch, LeAnn B Norris, P Brandon Bookstaver, Oliver Sartor, Charles L Bennett, None, Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. ,vol. 120, pp. 2464- 2471 ,(2014) , 10.1002/CNCR.28712